Great to have the Spark Valuation to give us some baseline figures.
I see any valuation as being a fluid object. Perhaps if the valuation was to be released after the top line data from Phase ! and the granting of ODD and other near term events, then we might be looking at launching the projections off a higher base to give us a different endpoint valuation.
And the assumption of MPL only capturing 10% of the addressable market seems a bit light on to me, especially if we become the new standard of care.
But it is informative to view the factors involved in a valuation.
- Forums
- ASX - By Stock
- PAA
- Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3, page-31
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $89.98M |
Open | High | Low | Value | Volume |
18.5¢ | 18.5¢ | 18.0¢ | $69.05K | 382.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 226676 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 291481 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 226676 | 0.180 |
10 | 511255 | 0.175 |
11 | 523656 | 0.170 |
3 | 47060 | 0.165 |
12 | 526554 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 291481 | 5 |
0.190 | 491386 | 8 |
0.195 | 687718 | 12 |
0.200 | 307726 | 11 |
0.205 | 221875 | 2 |
Last trade - 14.01pm 04/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |